News

OCRF Research Identifies Genetic Variations Increasing Ovar...

OCRF Research Identifies Genetic Variations Increasing Ovarian Cancer Risk

March 28, 2013

As part of a huge international effort involving more than 100 institutions and genetic tests on 200,000 people, researchers have discovered dozens of signposts in DNA that can help reveal further a person’s risk for breast, ovarian or prostate cancer.  The OCRF-funded Ovarian Cancer Association Consortium contributed to the ovarian cancer-related findings: five new genetic … Continued

OCRA News

The New York Times Publishes OCRF's Letter to the Edit...

The New York Times Publishes OCRF's Letter to the Editor 3/12/13

March 21, 2013

A frequent New York Times commenter on important ovarian cancer issues, OCRF wrote a Letter to the Editor in response to the NYT editorial, “Inadequate Treatment of Ovarian Cancer,” which was published in print and online on March 21, 2013. We are grateful for the opportunity to reach such a large audience regarding the importance of seeking … Continued

OCRA News

Night Shift Work May Increase Risk of Ovarian Cancer

Night Shift Work May Increase Risk of Ovarian Cancer

March 19, 2013

A study by researchers from the Fred HutchinsonCancer Research Center in Seattle found that women working the night shift may be at higher risk for ovarian cancer. The study of 3,322 women was published in the Journal of Occupational and Environmental Medicine.  NIght shift work was associated with a 24 percent higher risk of advanced ovarian … Continued

Research

Abagovomab As Maintenance Therapy in Patients With Epitheli...

Abagovomab As Maintenance Therapy in Patients With Epithelial Ovarian Cancer

March 18, 2013

In research published online on March 11, 2013 in the Journal of Clinical Oncology, researchers report on the results of a phase III, double-blind, placebo-controlled multicenter study that evaluated whether using abagovomab as maintenance therapy prolongs recurrence-free survival and overall survival in patients with ovarian cancer in patients in their first remission. This clinical trial was … Continued

Research

News from the SGO Annual Meeting

News from the SGO Annual Meeting

March 15, 2013

From March 9-12, 2013 top women’s cancer doctors from all over the world met in Los Angeles for the Society of Gynecologic Oncology‘s Annual Meeting on Women’s Cancer.  Lots of exciting research was presented at the meeting, representing the latest in the care and treatment of women with ovarian and other gynecologic cancers.  Highlights from research … Continued

Research

IP Chemo Shows Survival Benefit

IP Chemo Shows Survival Benefit

March 14, 2013

Two studies recently released show a survival benefit for intraperitoneal IP chemotherapy Women with the BRCA1 mutation given IP chemotherapy survived three years longer than those given IV chemotherapy. Read an article about the study here. A study presented at the SGO Annual Meeting showed an improvement in median survival of 10 months.

Research

New York Times Reports on Flaws in Ovarian Cancer Care

New York Times Reports on Flaws in Ovarian Cancer Care

March 12, 2013

The New York Times reported today on a study that found most women with ovarian cancer receive inadequate care. The article discusses research presented at the 2013 meeting of the Society of Gynecologic Oncologists (SGO), which found that women are more likely to get optimal care when treated at a medical center that handles a … Continued

Research

Our CEO Calaneet Balas Testifies Before Congress on Ovarian...

Our CEO Calaneet Balas Testifies Before Congress on Ovarian Cancer

March 8, 2013

Calaneet Balas, OCNA’s Chief Executive Officer, testified before the House Subcommittee on Labor, Health and Human Services, Education, and Related Agencies on Wednesday, March 13. Her remarks touched on the importance of federal funding for ovarian cancer education and research through the National Cancer Institute and Centers for Disease Control and Prevention. Summing up our … Continued

Advocacy

Enrollees in Cancer Clinical Trials Usually Healthier

Enrollees in Cancer Clinical Trials Usually Healthier

March 1, 2013

Often, patients enrolled in clinical trials live longer than those who are not, however, a new study shows that the survival benefit may be due to the patient’s health, not the treatment received in the clinical trial. Patients interested in clinical trials may also be more involved in decision making, which some believe affects outcomes. … Continued

Research

Press Release: Cancer Groups Praise Coverage of Genetic Cou...

Press Release: Cancer Groups Praise Coverage of Genetic Counseling and Testing Under Affordable Care Act, Urge Coverage of Other Vital Services

February 28, 2013

For immediate release: February 28, 2013 Washington, DC—The federal government recently released regulations that clarify which preventive services will be covered under the Affordable Care Act without cost sharing for patients enrolled in private insurance plans. Preventive services are provided without cost sharing to people enrolled in private plans that were established after August 1, … Continued

Advocacy

Partner Member Profile: "You'll Never Walk Alone&...

Partner Member Profile: "You'll Never Walk Alone"

February 26, 2013

Michele Robinson came up with the idea for her cancer support group, “You’ll Never Walk Alone,” during her first chemotherapy treatment for ovarian cancer in November 2004. “I was looking around the room and that song popped into my head. It was true—even though you do experience cancer yourself, no one knows what you feel … Continued

Community

More Evidence that IVF Does Not Increase Gyn Cancer Risk

More Evidence that IVF Does Not Increase Gyn Cancer Risk

February 22, 2013

New research published in Human Reproduction Update provides additional evidence that in vitro fertilization (IVF) does not increase women’s risk for ovarian, endometrial, and cervical cancer. Researchers have wondered if fertility treatments like IVF, which require the use of ovulation-stimulating drugs and the puncturing of the ovaries to retrieve eggs, increased women’s risk of gynecologic cancers.  Some … Continued

Research